Company Spotlight: Immune Design

Shares of Immune Design (IMDZ) are up an impressive 98% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index's gain of 26% during the same period.

from RTT - Biotech http://ift.tt/2xhX62S
via IFTTT